- Title:
Director/PDMR Shareholding - Time:
12:51:02 - Date:
16 Jun 2020 - Category:
Director/PDMR dealings - ID:
1349Q
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. |
Details of PDMR/person closely associated with them ('PCA') |
|||||
| a) |
Name |
Mr P Thomson |
||||
| b) |
Position/status |
President, Global Affairs |
||||
| c) |
Initial notification/ amendment |
Initial notification |
||||
| 2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
| a) |
Name |
GlaxoSmithKline plc |
||||
| b) |
LEI |
5493000HZTVUYLO1D793 |
||||
| 3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
|||||
| a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 |
||||
| b) |
Nature of the transaction |
Acquisition of Ordinary Shares following the exercise of options granted on 30 November 2016 at the option price of £12.95 per Ordinary Share under the Company's ShareSave Plan. |
||||
| c) |
Price(s) and volume(s) |
|
||||
| d) |
Aggregated information Aggregated volume Price |
N/A (single transaction) |
||||
| e) |
Date of the transaction |
2020-06-12 |
||||
| f) |
Place of the transaction
|
London Stock Exchange (XLON) |
||||
Director/PDMR Shareholding12:51:0216 Jun 2020Director/PDMR dealings1349Q